• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, June 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Impact Journals Backs Open Access Team in 2025 Ride for Roswell

Bioengineer by Bioengineer
June 10, 2025
in Cancer
Reading Time: 4 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Impact Journals Sponsors Open Access Team in 2025 Ride for Roswell

Impact Journals Announces Sponsorship of the Open Access Team in the 2025 Ride for Roswell, Fortifying Cancer Research Advocacy Through Scientific Publishing

Impact Journals, a prominent publisher recognized for its commitment to rapid dissemination of biomedical discoveries, has once again confirmed its sponsorship of the Open Access Team participating in the 2025 Ride for Roswell. This annual event, held on June 28, 2025, in Buffalo, New York, stands as one of the nation’s foremost cycling fundraisers dedicated to advancing cancer research. By intertwining the spheres of scientific publishing and community engagement, Impact Journals exemplifies how academic institutions and the public can collaboratively drive progress toward the eradication of cancer.

The Ride for Roswell, hosted by the esteemed Roswell Park Comprehensive Cancer Center, has garnered national attention for its comprehensive approach to cancer advocacy. It mobilizes thousands of riders, volunteers, and supporters from across the United States to not only raise crucial funds for scientific research but also to foster awareness and support for survivors and families impacted by cancer. The 2025 ride features nine distinct routes, ranging from a modest 4-mile journey to a grueling 100-mile challenge, all originating from the University at Buffalo North Campus, thereby accommodating participants of varying skill levels and dedication.

.adsslot_N2xqZm1w7J{ width:728px !important; height:90px !important; }
@media (max-width:1199px) { .adsslot_N2xqZm1w7J{ width:468px !important; height:60px !important; } }
@media (max-width:767px) { .adsslot_N2xqZm1w7J{ width:320px !important; height:50px !important; } }

ADVERTISEMENT

Central to the impact of this event is the Open Access Team, a collective underscored by a profound commitment to open scientific communication. Led by team captain Sergei Kurenov, the team symbolizes the intersection of medical science, publishing innovation, and patient advocacy. Their sponsorship by Impact Journals highlights a unique synergy, wherein open access publishing platforms not only accelerate the dissemination of cutting-edge cancer research but also actively participate in community-driven fundraising and awareness initiatives.

Open access publishing has revolutionized how scientific information is shared by removing traditional paywalls, thereby democratizing access to knowledge that can expedite breakthroughs in cancer treatment and prevention. Impact Journals, through its suite of open access publications including Oncotarget, Aging, Genes & Cancer, and Oncoscience, facilitates rapid peer review and immediate availability of research findings to a global audience. This model is essential for translational science where timely data sharing can influence clinical decision-making and policy development.

The team’s dedication gains a personal dimension through captain Sergei Kurenov’s reflections on his motivation. Having witnessed firsthand the challenges posed by cancer, including his father’s battle and the resilience of friends facing prostate and lung cancers, Kurenov channels these experiences into a decade-long commitment to this cause. His participation underscores a critical aspect of the event’s narrative: that beyond scientific innovation, cancer research is deeply human and requires sustained empathy and advocacy.

This year’s ride carries a poignant tribute to Dr. Mikhail (Misha) Blagosklonny, a visionary scientist whose pioneering research and leadership reshaped the landscapes of oncology and gerontology. Dr. Blagosklonny’s elucidation of mTOR signaling pathways and his advocacy for pharmacological interventions such as rapamycin have opened new horizons in understanding cellular aging and cancer proliferation mechanisms. His role as founding Editor-in-Chief of Oncotarget, Aging, and Oncoscience also marked significant strides in championing open access publishing, ensuring scientific knowledge remains freely accessible and widely disseminated.

The Ride for Roswell’s multiple route options not only test physical endurance but symbolize the multifaceted approach necessary to combat cancer. Scientific advancements require collaboration among diverse disciplines, from molecular biology and immunotherapy to epidemiology and bioinformatics. Events like this facilitate public involvement and underscore the essentiality of sustained funding streams for complex cancer research initiatives.

Support for the Open Access Team can be rendered via donations, team membership, or storytelling contributions, engaging a wide spectrum of stakeholders. This inclusive platform fosters communal responsibility and empowers individuals to participate actively in the protracted battle against cancer. Such participation ensures that cancer research funding does not remain siloed within academic or clinical settings but permeates public consciousness.

Impact Journals’ involvement exemplifies a broader paradigm shift within scientific publishing—where publishers are not merely passive conduits of information but active participants in research ecosystems and community outreach. The synergy between open access platforms and grassroots fundraising amplifies the reach and impact of cancer research endeavors.

With the 2025 Ride for Roswell poised to mobilize riders from around the country and beyond, the event represents a microcosm of the global commitment to improving cancer outcomes. The visibility afforded by such collaborations between publishers, researchers, and the community serves to accelerate the implementation of novel therapies, enhance patient education, and ultimately move society towards a future free of cancer’s burden.

Prospective participants and supporters are encouraged to visit the rally’s official channels to contribute toward this vital cause. Through the combined forces of science, philanthropy, and community spirit, tangible strides can be achieved in unraveling the complexities of cancer biology and delivering innovative solutions.

To explore more about the journals leading this transformative charge in biomedical publishing, and to learn how timely access to research fuels discoveries, interested readers can visit ImpactJournals.com. For direct communication or media engagements, Impact Journals remains accessible via [email protected], continuing its transparent and collaborative ethos.

Subject of Research:
Article Title:
News Publication Date: June 10, 2025
Web References:
https://rideforroswell.org/
https://www.roswellpark.org/
https://give.roswellpark.org/site/TR/SpecialEvents/General?team_id=23320&pg=team&fr_id=2020
https://www.oncotarget.com/
https://www.aging-us.com/
https://www.genesandcancer.com/
https://www.oncoscience.us/
http://impactjournals.com/
References:
Image Credits: Impact Journals ® is a registered trademark of Rapamycin Press LLC
Keywords: Cancer research, Cancer, Diseases and disorders, Health and medicine, Open access, Publishing industry, Digital publishing, Academic publishing, Scientific community, Scientific publishing

Tags: academic-public collaboration in researchbiomedical discoveries disseminationcancer survivor support initiativescommunity engagement in cancer advocacycycling for cancer awarenessdiverse cycling routes for fundraisingImpact Journals sponsorshipnational cancer advocacy eventsOpen Access Team 2025Ride for Roswell cancer fundraiserRoswell Park Comprehensive Cancer Centerscientific publishing and cancer research

Share12Tweet8Share2ShareShareShare2

Related Posts

Dr. David Craig at City of Hope

Rewrite City of Hope developed a foundational map of tumor cells for personalized brain cancer treatments this news headline for the science magazine post

June 13, 2025
Molecular and Histological Profiles and Relevant Imaging Signatures of Intrahepatic Cholangiocarcinoma

Rewrite Molecular and histological profiles and relevant imaging signatures of intrahepatic cholangiocarcinoma this news headline for the science magazine post

June 12, 2025

Rewrite Giving NK cells the upper hand in the battle against cancer this news headline for the science magazine post

June 12, 2025

Rewrite Vitamin D increases the likelihood that breast cancer will disappear with chemotherapy this news headline for the science magazine post

June 12, 2025

POPULAR NEWS

  • Green brake lights in the front could reduce accidents

    Study from TU Graz Reveals Front Brake Lights Could Drastically Diminish Road Accident Rates

    158 shares
    Share 63 Tweet 40
  • New Study Uncovers Unexpected Side Effects of High-Dose Radiation Therapy

    74 shares
    Share 30 Tweet 19
  • Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    67 shares
    Share 27 Tweet 17
  • How Scientists Unraveled the Mystery Behind the Gigantic Size of Extinct Ground Sloths—and What Led to Their Demise

    64 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Rewrite Repurposing the memory-promoting meclofenoxate hydrochloride as a treatment for Parkinson’s disease through integrative multi-omics analysis as a headline for a science magazine post, using no more than 8 words

Rewrite Some plants make their own pesticide — but at what cost to the atmosphere? this news headline for the science magazine post

Rewrite Murine maternal microbiome modifies adverse effects of protein undernutrition on offspring neurobehaviour as a headline for a science magazine post, using no more than 8 words

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.